The Brownstone Institute reported that a New York Times-profiled study claiming Ivermectin had no benefit for COVID-19 was funded by FTX. This revelation sparked discussion about the influence of Sam Bankman-Fried's exchange on medical research and the suppression of cheap, off-label treatments. Meanwhile, the CDC and FDA faced criticism for their shifting recommendations regarding the use of Ivermectin.



